Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $11.5 Million - $13 Million
60,048 Added 2.91%
2,121,808 $450 Million
Q2 2023

Aug 11, 2023

BUY
$187.64 - $206.25 $16.5 Million - $18.1 Million
87,737 Added 4.44%
2,061,760 $397 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $7.24 Million - $11.5 Million
56,750 Added 2.96%
1,974,023 $400 Million
Q4 2022

Feb 13, 2023

BUY
$117.37 - $139.17 $6.59 Million - $7.82 Million
56,176 Added 3.02%
1,917,273 $246 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $8.26 Million - $11 Million
61,044 Added 3.39%
1,861,097 $254 Million
Q2 2022

Aug 12, 2022

BUY
$108.81 - $179.33 $57,125 - $94,148
525 Added 0.03%
1,800,053 $318 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $8.57 Million - $11.3 Million
71,628 Added 4.15%
1,799,528 $259 Million
Q4 2021

Feb 11, 2022

BUY
$142.57 - $190.86 $7.82 Million - $10.5 Million
54,818 Added 3.28%
1,727,900 $267 Million
Q3 2021

Nov 12, 2021

BUY
$142.45 - $169.82 $5.04 Million - $6.01 Million
35,391 Added 2.16%
1,673,082 $284 Million
Q2 2021

Aug 13, 2021

BUY
$135.08 - $161.1 $9.55 Million - $11.4 Million
70,727 Added 4.51%
1,637,691 $258 Million
Q1 2021

May 12, 2021

BUY
$137.51 - $190.8 $10.7 Million - $14.9 Million
78,138 Added 5.25%
1,566,964 $217 Million
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $245 Million - $316 Million
1,488,826 New
1,488,826 $260 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.